The Journal of Leukocyte Biology requires that all authors read this section thoroughly and completely and all submissions be made online. After reading the following information, visit www.jlb-submit.org to begin the online submission process.
ScopeManuscripts
Submitted from
the Institution of an Editor
Manuscripts submitted from the institution of any Board Member,
Associate or Deputy Editor, or the Editor-in-Chief are reviewed by
other editors from outside that institution. The Editorial Office
ensures confidentiality and equity in reviewing all manuscripts.
Prior
Publication
Authors should confirm that no similar paper (including book chapters)
has been or will be submitted elsewhere. As an aid to reviewers, any
unpublished articles that are related to, or could be perceived to
overlap with, the submitted manuscript must be included as supplemental
data.
Open
Access Option
Authors of accepted manuscripts may have their articles made freely
accessible on the journal’s web site and on PubMed Central
immediately upon final publication by paying an open access fee. The
fee is $2,500 (USD) per article and is in addition to other author
fees, such as page charges, color charges, reprints, etc. If you are
interested in this option, please
click
here to download and complete this form.
Authors who received funding from agencies with open access publishing
requirements should be able to comply with funding requirements by
selecting the open access option. (The journal will make a reasonable
effort to help authors comply with these requirements, but ultimate
responsibility for funder compliance, however, remains with the
authors.) For these authors, upon payment of the fee, the journal will
deposit the final version of the author’s article in PubMed
Central (PMC) and will authorize public posting on PMC and PMC mirror
sites immediately upon final publication of the article. Please note
that preprint versions of article are not the final versions and will
not be deposited.
NIH
Public Access Policy
Under the NIH Public Access Policy, NIH requires that all manuscripts
(accepted after April 7, 2008) which resulted from research supported
in whole or in part by NIH funds be submitted to PMC. The Society for
Leukocyte Biology (SLB) will upload final published NIH-funded articles
to PMC and will notify PMC to make the article free 12 months after
final publication. This time period is consistent with existing policy
which makes content publicly available 12 months after print
publication, and assures compliance with the SLB copyright agreement.
Questions regarding NIH Public Access Policy and the publication of
your article in JLB should be directed to Jennifer Pesanelli at jpesanelli{at}faseb.org.
Competing
Financial Interests
All authors are expected to disclose any arrangements that could be
considered to pose a financial conflict of interest regarding the
submitted manuscript. Potential conflicts of interest must be described
in the cover letter. All funding sources, institutional and
corporate, must be credited in the Acknowledgments section.
Microarray/Genomics/Proteomics
Data
JLB will not publish descriptive manuscripts that report
microarray/genomics/proteomics data, unless such information can be
considered of unusual immunological significance and/or include
functional experiments that provide novel insight into mechanism. As
with other scientific approaches, current experimental, quantitation,
verification, and statistical analyses are expected. Microarray
experiments should be Minimum
Information About a Microarray Experiment-compliant (MIAME).
Whereas limited online space may be available for supplemental tables
associated with the manuscript, complete microarray data must be
deposited in the appropriate public database (e.g., GEO,
ArrayExpress,
or CIBEX),
and must be accessible without restriction from the date of
publication. An entry name or accession number must be included in the
paper before publication. The accession number should be accompanied by
the website address of the databank
Ethics
Committee Approval
Human
experiments: All work
must be conducted in accordance with the Declaration of Helsinki.
Papers describing experimental work on human participants must include:
(1) a statement that the experiments were conducted with the
understanding and the consent of each participant, and (2) a statement
that the responsible ethical committee has approved the experiments.
Animal experiments: Articles describing experiments on living animals must include: (1) a full description of any anesthetic and surgical procedure used; (2) the source of institutional approval of methods; and (3) evidence that all possible steps were taken to avoid animals' suffering at each stage of the experiment. In experiments involving the use of muscle relaxants, a description of the precautions taken to ensure adequate anesthesia [J. Physiol. (1990) 420, xii–xiii] must be included.
Misconduct
JLB accepts research papers that are original works, no part of which
has been submitted for publication or published elsewhere except as
brief abstracts. Duplicate publication, falsification, plagiarism, or
fabrication will be considered actionable misconduct. Misconduct does
not include honest error or honest differences in interpretations or
judgments of data.
If there is a suspicion or allegation of misconduct directed toward any author, JLB reserves the right to forward relevant material to the appropriate authorities at the author's institution for investigation. JLB recognizes its responsibility to ensure that the suspicion of misconduct has been addressed, but the journal does not make such determinations. Issues relating to contested authorship will be handled by the same procedure.
The Editor-in-Chief is responsible for the journal’s editorial conduct and compliance with relevant policies and procedures. When a report of suspected misconduct has been sent to the Editor-in-Chief, the following course of action will be taken. If the manuscript has yet to be published, all work on the manuscript will stop. No immediate action to published material (such as retracting the online preprint) will be taken until the matter is resolved. The Editor-in-Chief will write the corresponding author asking for an explanation in a nonjudgmental manner. Should the author's response fail to resolve the situation satisfactorily, the Editor-in-Chief will contact the institution of the corresponding author. The institution should then make an inquiry and report back to the Editor-in-Chief. Until the matter is clarified, no papers by any authors of the disputed manuscript will be considered for publication.
If scientific misconduct is confirmed by institutional review, the Editor-in-Chief will decide upon the appropriate action. Violations considered severe may warrant official withdrawal of a published article or rapid rejection of a manuscript at any stage before publication. If the infraction is less severe, the Editor-in-Chief will send the corresponding author a letter of reprimand. If no scientific misconduct is found, the manuscript (if unpublished) will be scheduled for publication. For errors in a published article not deemed to be misconduct, an Erratum or Letter to the Editor will be published.
Press
Access
Members of the press, public affairs officers, and other science
writers may request pre-publication copies of articles. Usually these
articles are available on the journal’s web site as
preprints.
Credentialed members of the press may request free online access to the
journal. For further details, please contact Cody Mooneyhan at cmooneyhan{at}faseb.org,
phone (301) 634-7104.
Errata
JLB makes every effort publish error-free manuscripts by providing
authors with page proofs before publication. There are occasions,
however, when it is necessary to publish a correction. Errata may be
sent directly to Gail Fallon, Production Manager, at gfallon{at}faseb.org.
Ready
to Submit
After all the required manuscript information described above has been
gathered, go to www.jlb-submit.org
and follow the prompts.
Submission
Process
The submission process has four steps: Files, Manuscript Information,
Validate, and Submit. Each step contains sub-steps that can be accessed
by clicking on their respective tabs. Navigating through this
“Tab View” will save any entered information each
time a
new tab is clicked (or if the boxes “Save and
Continue” or “Next” are clicked). The
steps and
sub-steps are:
Revised
Manuscripts
Authors will be allowed nine months to submit a revised
manuscript. Papers that are not returned within nine months
of
the date of the decision letter will be considered as NEW and will be
subject to a complete review. Revised papers will be
re-evaluated
by the all or some of the original reviewers and Editors.
Manuscript submission information should adhere to all manuscript
requirements, with an additional emphasis on Figure format (see
Mandatory
Manuscript and
Artwork Requirements When Submitting Revised
Manuscripts)
Brief
Conclusive Reports
These are short reports of outstanding interest that focus on new and
important findings. This format is intended for exciting observations
that have the potential to open up new avenues of research and can be
described using fewer figures and less text than an Article. They
should consist of a 200 word abstract, a brief materials and methods
section (~3,000 characters), text as noted below, and should not exceed
eight double-spaced pages of 12-point type or 22,000 characters (not
counting spaces and not taking into account Material and Methods or
Reference sections). The manuscript should include no more
than 6
figures and/or tables, and no more than 40 references. Brief Conclusive
Reports contain the same sections as Articles; however, Results and
Discussion must be combined. Brief Conclusive Reports contain the
following sections, in this order: Title Page, Abstract (200 words),
Introduction, Materials and Methods, Results and Discussion,
Authorship, Acknowledgments, References, Figure Legends, Tables and
Figures.
Pivotal
Advance
An article or Brief Conclusive Report may be submitted as a Pivotal
Advance when authors believe that their work represents a relatively
high level of accomplishment. A manuscript submitted for consideration
as a Pivotal Advance is subjected to additional review by
JLB’s
editors for scientific novelty, originality, quality of approach, and
overall impact. If a manuscript is accepted as a Pivotal Advance after
review, the editorial board member or one of the referees will be asked
to contribute a corresponding editorial commentary that will be
published online and in print with the article. A manuscript submitted
in the Pivotal Advance category that is acceptable for publication, but
does not qualify as a Pivotal Advance will be published as regular
research article. To have a manuscript considered for the Pivotal
Advance category, authors should include a paragraph in their cover
letter indicating why they consider their findings to represent a very
high level of accomplishment. In addition, a manuscript not submitted
as a Pivotal Advance may be selected by the editors to be published as
a Pivotal Advance.
Invited
and Author-Initiated
(Unsolicited) Reviews and Mini-Reviews
The journal publishes full-length invited and uninvited review
articles. Format for reviews should follow those described for
“Articles.” At time of publication, reviews with
<75
references and three illustrations (figures/Tables) or less will be
categorized as “Mini-Reviews” whereas those that
include
added references/illustrations will be categorized as
“Reviews.” All reviews will
require a summary
sentence that should include scope of review. Authors are encouraged to
include words such as “…expands the
argument…”, “…focuses on
the…”,
“….discusses the….”,
“….challenges the…”, etc.
Letters
to the Editor
Letters to the Editor commenting on recently published work in the
journal (articles, editorials, etc.) are welcomed. These may be
published at the discretion of the Editor-in-Chief who reserves the
right to make minor changes in the text to improve the
composition. If appropriate, the authors of the original work
will be invited to respond and these letters will be published in
tandem in the same issue. Letters to the Editor should be
500-1,000 words, with up to six references, and should follow the
formatting conventions for the JLB.
Editorial
Commentary
Personal perspectives on published articles are solicited by the
Editors. Editorials should provide a focused discussion of the paper
from a wider perspective and be provocative and insightful to readers
wanting to know about where the field is headed. In order to make this
feature complementary to the paper rather than a restatement of
conclusions, visuals reviewing current dogmas and gaps in knowledge,
tables with open questions, or controversies citing opposing papers are
invited and encouraged. Editorials should be no longer than
two
published journal pages, i.e., 1,000–2,000 words in length
(including figure legends and no more than 10 references) and one
illustration figure or table as noted above. Include a short
“perspective-based” title (e.g., “Toll
receptors lost
in translation,” “Heart and inflammation: new life
to old
foe,” “BCG and T-regs: who
knew?”). Editorials
are intended to serve as an aid to placing findings in a larger context
from the perspective of a leader in the field with a focus on future
research and the directions these findings may open. As much as
possible, editorials should not be conceptually redundant with the
discussion angle provided by the article’s authors, nor
should
they seek to serve as comprehensive reviews. Commentaries may be more
insight- and opinion-based.
Editorials require a summary
sentence. Authors are
required to include in summary sentence that describes the
scope
of commentary with words such as “…expands the
argument…”, “…focuses on
the…”,
“….discusses the….”,
“….challenges the…”,
etc.
At submission online authors are requested to copy and paste the first
introductory paragraph into the abstract box of the online submission
form.
If you would to like to submit a response to a published Editorial Commentary by a “counter-commentary” or Letter to the Editor, please contact the Editor-in-Chief.
Meeting
Article
Invited
research articles will follow the guidelines as described above for
Articles but are submitted with an established deadline as part of a
cluster of articles from a focused scientific meeting. They will
be published under a special section in the Journal referred to in the
Table of Contents as “Current Topic Overview” (note review/article
.pdfs will not have this label). All manuscripts submitted
under this mechanism must still meet the priority criteria of a regular
research manuscript, following peer review and be based on
communicating new and important findings in the field (meeting article
manuscripts will be labeled as regular “Articles” in final
publication).
Please refer to the instructions
for regular Articles above for a detailed description. As
articles, they should contain the following sections in this order:
Title Page (title, author listing, etc), Abstract (250 words),
Introduction, Materials and Methods, Results, Discussion, Authorship
(contribution description), Acknowledgments, References, Figure
Legends, Tables and Figures.
Meeting
Brief Conclusive
Report
Invited
Meeting Brief Conclusive Reports follow the guidelines above for Brief
Conclusive Reports, but are submitted with an established deadline as
part of a cluster of articles from a focused scientific meeting. They
will be published under a special section in the Journal referred to in
the Table of Contents as “Current Topic Overview” (note review/article
.pdfs will not have this label).
Please refer to the instructions for Brief Conclusive Reports (above). As a BCR, they should contain the following sections in this order: Title Page, Abstract (200 words), Introduction, Materials and Methods, Results and Discussion, Authorship (description of contributions), Acknowledgments, References, Figure Legends, Tables and Figures.
Meeting
Overview Reviews and
Mini-Reviews
Invited
Meeting Overview Reviews should cover the content of a recent
presentation in the context of the field in general and be in Review
Article style, but are submitted with an established deadline as part
of a cluster of articles from a focused scientific meeting
Description of primary research not yet published should not be
included since a review format does not allow authors to present data
as in a research Article (a leading reason for rejection of an
overview).
Meeting Overview Reviews should address
emerging or evolving concepts related to the field; i.e., they should
not merely reiterate well-established concepts that do not need
critical review. Readers see these critical overviews as an aid in
defining future directions for the field rather than an exclusive
summary of the author’s presentation at a meeting.
At time of
publication, reviews with <90 references and three illustrations
(Figures/Tables) or less will be categorized as “Mini-Reviews” whereas
those that include added references/illustrations will be categorized
as “Reviews.” All reviews will require a summary sentence
that should include scope of review such as “…expands the argument…”,
“…focuses on the…”, “….discusses the….”, “….challenges the…” etc.
Manuscript
Organization
Articles should be organized as follows: Title page, Abstract,
Introduction, Materials and Methods, Results, Discussion,
Acknowledgments, Authorship, References, Figure Legends, List of
Abbreviations, Tables and Figures. For Brief Conclusive Reports,
Results and Discussion must be combined. Reviews should be organized as
follows: Title page, Abstract, text with labeled subtopics, Concluding
Remarks, Acknowledgments, Authorship, References, Figure Legends, List
of Abbreviations, Tables and Figures. Page numbers must be incorporated
at the bottom of each page of the text document. Explanatory
footnotes should not be used; include the information within the text
of the manuscript.
Format
requirements
Text must be in a 12-point font (not compressed) and double line-spaced
throughout. Each of the bulleted elements listed below should start on
a new page; all elements should appear in the order listed.
Abbreviations Page: The abbreviations page should immediately follow the title page and should contain an alphabetized list of all abbreviations used in the article, as well as each abbreviation's definition.
Abstract: The abstract should not exceed 250 words (200, if a Brief Conclusive Report). Include rationale, objectives, a hypothesis (if primary research is described), species of cells/animals involved, main findings, and conclusions. We suggest authors start the abstract with a sentence similar to “This study tested the hypothesis that…” and conclude with a statement which indicates whether or not the hypothesis was supported.
Introduction: The
introduction should provide readers with backgroundon the
research reported in the manuscript. It sets the stage for the paper by
putting your topic into perspective for readers.
Materials and Methods: The
Materials and Methods section should contain experimental protocols and
describe the origin of any unusual or special materials, tissue, cell
lines, or organisms. It is appropriate in this section to provide data
to support the identity or purity of reagents, the reliability of
methods, the sensitivity of an instrument, or the essential features of
a genotype. Companies mentioned in this section should include the name
of the company and location (city, state/province, and country).
Authors should put most of the experimental detail into the Materials
and Methods section, leaving the Results section for exposition of the
experimental design and results.
Results: Data included should be original, fully labeled, and essential to the report. Text should be presented with concise, accurate subheadings. (In Brief Conclusive Reports, Results and Discussion sections are combined.)
Discussion: This section should expand on the information included in the results section. Care should be taken not to merely reiterate statements made in the previous section but to discuss the pertinence and import of the findings. (In Brief Conclusive Reports, Results and Discussion sections are combined.)
Figure Legends: Include a short title after the figure number and follow with a short explanation (ideally no more than 150 words) which provides sufficient detail to make the data intelligible without reference to the text. Methods described in detail in the Materials and Methods section should not be repeated in the legend.
Authorship: List contributions made by each of the authors to the article. People listed as authors must be able to justify their participation in the study and should have substantially contributed to the study’s conception, design, and performance. Co-Principal Investigators may be identified here as well.
Acknowledgments: Acknowledgements should be made only to those who have made a substantial contribution to the study. Authors are responsible for obtaining written permission from individuals acknowledged by name since readers infer their endorsement of data and conclusions. Sources of funding must be placed in this section.
References: Reference citations should appear in numerical order in brackets throughout the text. The reference list should be double-spaced on a new page at the end of the paper, and references should be numbered consecutively in the order in which they are cited. List all authors and inclusive pages.
Unpublished experiments, personal communications, or papers submitted for publication should not be included in the reference list but should appear parenthetically in the text as “unpublished results.” Written approval by the person(s) cited in personal communications must accompany the manuscript. (You may upload these approvals in the supplemental file section of the manuscript submission system. If this approval exists only in physical form, please scan it and upload as a PDF.) Papers accepted but not yet published may appear in the reference list with the name of the journal followed by the words “In press.” One copy of each reference in press must be submitted with the manuscript. (These copies may be submitted in the supplemental file section of the manuscript submission system.)
Abbreviations of journals should conform to those used in Index Medicus, National Library of Medicine. The following style should be used:
Videos
Inclusion of videos with the online version of the published paper is
at the discretion of the editors; the editors also may determine that
some videos should be published online as supplemental information.
Discs, videotape, etc. containing videos or audio will not be inserted
into or mailed with the printed journal.
Video submissions for viewing online should be in one of the following
formats: .avi, .mpg, or .qt, or .mov. Videotape and film are not
accepted.
Videos should be brief whenever possible (2–5 minutes).
Longer
videos will require longer download times; editors, reviewers, and
readers may have difficulty playing online. Videos should be restricted
to the most critical aspects of your research. A longer procedure can
be restructured as several shorter videos and submitted in that form.
Please compress files to use as
little bandwidth as possible and to
avoid excessive download times. It is recommended that video files be
no larger than 5 megabytes.
A caption with a brief description should be provided for each video
and submitted in a separate document in either .doc or .rtf formats.
If a paper is accepted for publication authors may wish to supply the
editorial office with several different resolutions of the video files
for posting online. This allows viewers with slower connections to
access the video.
Mandatory
Manuscript and
Artwork Requirements When Submitting Revised Manuscripts
When submitting revised manuscripts for re-review to the Journal of
Leukocyte Biology, following these instructions will ensure the fastest
and highest quality publication of your article, if your article is
given final acceptance for publication.
Text Files: Revised Manuscripts, Tables,
and Figure Legends
Authors should follow the same instructions for preparing manuscripts
as they did when first submitting to the journal. In short, manuscripts
and tables should be submitted in MS Word (.doc), and Rich Text (.rtf)
formats only. At this stage, other formats, such as .pdf,
will
not be accepted for text files.
Image Files: Figures
Each figure must also be submitted as a separate file (i.e. figure 1 is
its own file, figure 2 is its own file, etc.) and must be clearly named
and labeled (i.e figure 1 is labeled figure 1 and named figure 1).
Figure files for revised manuscripts must be submitted in the following
formats:
Figure File Formats:
1) Vector EPS files: Vector graphics
provide the
highest quality for figures that contain any text or wording.
2) Rastered TIFF files: Tiff files must
be supplied
at the following resolutions:
a) Halftones
(pictures) - 300 dpi.
b) Combination
halftones (combination of pictures and text labeling) - 600 dpi.
c)
Monochrome/line art images (pure black and white with no grayscale) -
1200 dpi.
3) PDF files: PDF files must be created
using the
proper Acrobat Distiller options. Complete
instructions for
creating optimized PDF files can be found by clicking here.
4) Microsoft PowerPoint: PowerPoint files will be
accepted, but must be created properly if they are to be used for
publication. Artwork embedded into PowerPoint must meet the same
resolution requirements as TIFF files. Fonts allowed in PowerPoint
files are Arial, Helvetica, Times new Roman and Symbol.
DO NOT supply files in other formats, such as GIF, JPEG, BMP, PNG, etc.
Other image file formats are usually poor quality and not intended for
print publication. Supplying files in any format other than vector EPS,
rasterized TIFF, “press quality” PDF, or PowerPoint
will
cause the manuscript to be returned prior to review, possibly causing
publication delays. any software products exist that can produce figure
files suitable for publication, including programs that can be
downloaded for free online. Of all products available for free and for
purchase, Adobe software is highly recommended for processing and
submitting your digital artwork.
Color:
Color artwork must be supplied as RGB and NOT CMYK.
Figure Size and Layout:
1) Figures must be cropped and supplied as close
to final
size as possible. Preferred size is 3.5 inches for 1-column
images, 5 inches for 1½-column images, and 7.25 inches for
2-column images.
2) Multiple panel layouts must only have .25 inch
space
between parts. Layouts must contain as little
“white
space” as possible. To view sample layouts click
here.
Fonts and text size:
1) Arial, Helvetica, Times New Roman and Symbol
are
required fonts for digital artwork. Deviating from these
standard
fonts will cause publication delays as figures will be returned to
authors for correction. All fonts must be embedded when
saving
files.
2) Figure text size must be 7-10 pt.
3) Figure part labels (i.e. A, B, C, etc.) must be
12 pt.
Helvetica Bold and placed in a white square in the upper left corner of
all figure parts. Please be sure to use capital letters for figure part
labels.
Text size will change if figure needs to be reduced or
increased.
Supplying 1 column figures at sizes greater than 3.5 inches will result
in smaller text when size is decreased. The same rule applies
for
increasing figures.
Cover Submissions:
The journal cover includes space for an illustration that changes every
month. We invite you to bring to our attention any illustrations that
you feel would make a particularly attractive cover. These may be
figures from your paper or designs that reflect its subject
matter. A brief cover legend should be submitted with the
image.
Additional information can be obtained from Amy Huter-Imming at jlb{at}journalstaff.com.
Online
Supplemental Material [Back
to Top]
Essential information that cannot be presented in the printed journal,
such as large data sets or videos, can be included as supplemental
material. Supplemental figures and tables that are not essential to the
conclusions of the paper, but are both useful and important, may also
be included online. Supplemental material must be cited both at the
relevant place in the manuscript and in the legends of any related
figures. A paragraph providing a brief description of each
item
must appear at the end of the Materials and Methods section under the
heading “Online Supplemental Material.”
All material submitted as supplemental material should have a legend or short explanation explaining what is included. Figures and videos must also be accompanied by a text legend. All supplemental material will be peer reviewed with the manuscript and approved by the editors, but supplemental material will be posted online “as is” without copy editing, layout or any other revision or modification by journal staff.
“Extended Methods” may be published online when needed. Extended Methods may not replace or repeat the Materials and Methods section of the main paper. Extended methods should be noted in Materials and Methods Section of the main text as available online.
Links to supplemental material will appear in two places in the online journal: in the Table of Contents and in the information on the first page of the full-text article. In the print version, the availability of additional online material will be indicated in a footnote on the first page of the article: “The online version of this paper, found at www.jleukbio.org includes supplemental information.”
Copyright
Assignment
and Publication Costs Agreement Form [Back
to Top]
Authors are required to sign a Mandatory Copyright Assignment and
Publications Agreement Form when they submit a manuscript. Authors of
NIH-funded manuscripts must submit the appropriate NIH form with the
journal’s Mandatory Copyright Assignment and Publications
Agreement Form attached.
Accepted
Manuscripts [Back
to Top]
With the cooperation of the authors, research papers are published
online within 3–4 weeks of acceptance or receipt of the final
and
complete version, including figures and files in the correct
formats. Manuscripts are normally published in final online
format and in print within 3-6 months of receipt of the proofs and all
pertinent information.
Proofs
Galley proofs are supplied to the corresponding author as a PDF, along
with instructions. Proofs must be returned within 48 hours.
Costs
Excessive alterations to page proofs may lead to additional charges to
authors. Page charges for published articles are as follows:
Up
to 8 pages:
For SLB members: $35/per printed page
For non-SLB members: $50/printed page
9+
pages:
For SLB members: $70/per printed page
For non-SLB members: $100/printed page
PLEASE NOTE: You have the option of joining the Society for Leukocyte
Biology when you submit your accepted paper. Click here for an application form.
Color:
The first page of color will be billed at $450. Additional pages in the
same articles will be billed at $300 each. Checks should be made
payable to the Journal of Leukocyte Biology.
Author
Billing and Reprint
Purchases [Back
to Top]
Authors will be billed using an online payment system. For those who
cannot pay by credit card, this system allows authors or their
representatives to obtain an invoice, as well as instructions for
paying by check or wire transfer. Please note: Authors needing an
invoice must obtain one through the online bill payment system, as
staff are unable to generate invoices in any other way. The
corresponding author will receive an e-mail 1-2 weeks before the month
of publication containing instructions to pay online. Authors cannot be
billed in advance of this time.
Reprints [Back to Top]
Reprints may be ordered in multiples of 50. Authors will be given
the
opportunity to purchase reprints through the online bill payment system
when they pay their publication charges. Non-authors should contact lkimble{at}faseb.org
to purchase reprints of published articles.